Natco gets approval for first Sovaldi generic in India
This article was originally published in Scrip
Executive Summary
Natco Pharma has received regulatory approval to launch generic sofosbuvir tablets 400mg in India –the first company to get such clearance in the country.
You may also be interested in...
First Sofosbuvir WHO Prequalification To Widen Access But How Far?
WHO’s prequalification of the first sofosbuvir from Gilead licensee Mylan is expected to expand access to the HCV treatment, but much will depend on donor funding priorities, say experts. Gilead hopes direct negotiations with payers in certain territories can move the access needle further.
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.
India IPR Wheels Are Turning: Novartis, Bayer, Sun, Legal Heads Discuss Realities
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.